Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Pharmaxis Ltd ( (AU:SNT) ).
Syntara Limited reported its quarterly cash flow, revealing a net cash outflow from operating activities of $3.737 million for the current quarter and $11.119 million for the year to date. The company saw a net cash inflow from investing activities of $866,000 for the quarter and $4.179 million for the year, with no significant cash flow from financing activities during the quarter. The report highlights the company’s financial management and cash position, providing insights into its operational efficiency and investment strategies.
The most recent analyst rating on (AU:SNT) stock is a Buy with a A$0.12 price target. To see the full list of analyst forecasts on Pharmaxis Ltd stock, see the AU:SNT Stock Forecast page.
More about Pharmaxis Ltd
Average Trading Volume: 9,771,429
Technical Sentiment Signal: Sell
Current Market Cap: A$97.56M
Find detailed analytics on SNT stock on TipRanks’ Stock Analysis page.